I like the Reasons to be Cheerful (1,2,3), and pleased to have...

I like the Reasons to be Cheerful (1,2,3), and pleased to have the list of other items to look out for that could help a re-rate.

I am a glass is half empty sort though, and my reading of Doug's tone in the vid was definitely more along the lines of "steady as she goes, upcoming drop in ViraDX sales to be expected, big gains not till CLIA waiver achieved" but then, it is open to interpretation, i will be glad to be proved wrong.

Having said that though, re your point " FDA will assess results and likely issue CLIA waiver in the following year 2025.", i am convinced he said 2026 in the vid, and i listened back a couple of times to be sure (hence my wondering if he got himself mixed up with his flu seasons, as I definitely want to believe it is earlier than that).

I hope he mis-spoke. But having been in and out of a few bio and med techs, and having chronic illness in the family whereby on a personal level we are hanging out for new technology to make it through various trial phases, the trials (setting up, running them, and evaluation afterwards) tend to be drawn out processes.